Lehrstuhl für Innere Medizin V

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma (2018) Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, et al. Journal article CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells (2018) Jitschin R, Saul D, Braun M, Tohumeken S, Kischel R, Lutteropp M, Dos Santos C, et al. Journal article TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes (2018) Erber R, Hartmann A, Beckmann M, Mackensen A, Kremer A, Reimann H, Hübner H, et al. Journal article Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN (2018) Schlichtig K, Lechner P, Grafe C, Ferstl B, Fuchs F, Hein A, Meidenbauer N, et al. Conference contribution Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions (2018) Spriewald BM, Bach C, Zingsem J, Strobel J, Winkler J, Mackensen A, Rösler W Journal article TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes (2018) Würfel F, Erber R, Hübner H, Hein A, Lux MP, Jud S, Kremer A, et al. Journal article Impact of collection programs for the generation of monocyte apheresis products on product quality and composition as starting material for the generation of cellular therapeutics (2018) Pfeiffer H, Gary R, Mackensen A, Achenbach S, Strasser E, Aigner M, Völkl S Journal article Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells (2018) Braciak TA, Roskopf CC, Wildenhain S, Fenn NC, Schiller CB, Schubert IA, Jacob U, et al. Journal article D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization (2018) Böttcher M, Renner K, Berger R, Mentz K, Thomas S, Cardenas-Conejo ZE, Dettmer K, et al. Journal article Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway (2018) Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, et al. Journal article